ASTRAZENECA PLC (AZN)
Clinical trial NCT06795022 updates: 1. completion date: 2028-07-25 → 2028-06-30 2. primary completion date: 2028-02-25 → 2027-06-30
Clinical trial NCT06795022 updates: 1. completion date: 2028-07-25 → 2028-06-30 2. primary completion date: 2028-02-25 → 2027-06-30
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical